ArticleCancer management and research2022

The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional Study.

Michela Roberto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.